TrovaGene

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch TrovaGene and buy or sell other stocks, ETFs, and their options commission-free!

About TROV

Cardiff Oncology, Inc. is an oncology therapeutics company, which engages in the development of drugs that target mitosis for the treatment of various types of cancer. It is focused on developing onvansertib, a first-in-class, third-generation Polo-like Kinase 1 (PLK1) inhibitor, in combination with standard-of-care chemotherapy and targeted therapeutics. 

CEO
Mark Erlander, PhD
CEOMark Erlander, PhD
Employees
33
Employees33
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
1999
Founded1999
Employees
33
Employees33

TROV Key Statistics

Market cap
79.16M
Market cap79.16M
Price-Earnings ratio
-3.09
Price-Earnings ratio-3.09
Dividend yield
—
Dividend yield—
Average volume
1.20M
Average volume1.20M
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$5.64
52 Week high$5.64
52 Week low
$2.01
52 Week low$2.01
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.